Zhejiang Maoyuan Sunflower Pharmacutical Co., Ltd. China (Mainland)

Hangzhou Sunflower Technology Development Co., Ltd. was set up by the professor and senior engineer and the main creator of Chinese PVP - Mr. Wu Jiaxiang. Hangzhou Sunflower Technology Development Co., Ltd. has a lot of technical professionals and marketing talents, who have many years of experience in the line. We have possessed techniques of several specialty chemicals such as Polyvinylpyrrolidone (PVP) series, and Chondroitin sulfate sodium (CS) and its relative intermediates. With 30 years' experience in research and manufacture, we keep the leading position in China by a full range of products which are high-purity, light in color and odorless. Zhejiang Maoyuan Sunflower Pharmaceutical Co. Ltd. is a subsidiary joint venture of Hangzhou Sunflower Technology Development Co., Ltd., which has 30 years of experience in drug manufacture. We have five sets of GMP production lines for transfusion injections, tablets, solutions, APIs, and excipients, and the production licenses of 35 drugs, APIs and excipients. We are the only manufacturer of cuttlefish hemostats which are extracted from marine cuttlefishes in China. Our Povidone and PVP-I are the only products in the field that have got GMP certificate issued by SFDA and DMF certificate issued by FDA. The European COS certificate is expected to be attained in 2010. Our holding company - Huzhou Sunflower Performance Polymer Co. Ltd. has GMP production lines with an annual output of 300 tons of high molecular weight PVP (K60, K90, K120) powder and 100 tons of Chondroitin Sulfate Sodium with high purity. We have the biggest consecutive low temperature drying devices for PVP and the most advanced extract technology for Chondroitin Sulfate Sodium in China. The biotechnology and the extractive which have advantages in both sources and technology will be the new development target of Huzhou Sunflower Performance Polymer Co. Ltd. We are now developing the artificial cultivating cordyceps and related extractive. The base with an annual output of 20 tons of artificially cultivating cordyceps is under construction and will be put into production in 2010.